drugset / Trial / NCT00385099

Effects Of GW876008 On The Bowel In Patients With Irritable Bowel Syndrome

NCT00385099

Phase 2 Completed 10 enrolled GlaxoSmithKline
RandomizedCrossoverTreatment

Summary

The purpose of this study is to see if GW876008 in Irritable Bowel Syndrome patients will reverse stress-induced hypersensitivity, by looking at thresholds for perception and pain.

Timeline

Start
2006-12-08
Primary completion
2007-10-15
Completion
2007-10-15

Drugs

EvaluationDrugModalityDoseRoute
Subject EMICERFONT Small molecule